|
| |
| | | 65694 | | 17.09.2015 | | Mepha Pharma AG | | | | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Gliclazid-Mepha Teva MR 30 mg | Retardtabletten | Delayed release tablets (Gliclazide 30 mg) | A10BB09 | CI | | 02 | Gliclazid-Mepha Teva MR 60 mg | Retardtabletten | Delayed release tablets (Gliclazide 60 mg) | A10BB09 | CI |
|
|
|
